KR880001313B1 - Method for preparing tetrahydroindole derivative - Google Patents
Method for preparing tetrahydroindole derivative Download PDFInfo
- Publication number
- KR880001313B1 KR880001313B1 KR1019830002036A KR830002036A KR880001313B1 KR 880001313 B1 KR880001313 B1 KR 880001313B1 KR 1019830002036 A KR1019830002036 A KR 1019830002036A KR 830002036 A KR830002036 A KR 830002036A KR 880001313 B1 KR880001313 B1 KR 880001313B1
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- hydroxy
- tetrahydroindole
- oxo
- semicabazono
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 15
- FRUWMYWEARDNTC-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-indole Chemical class C1C=CC=C2NCCC21 FRUWMYWEARDNTC-UHFFFAOYSA-N 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 39
- 235000017281 sodium acetate Nutrition 0.000 claims description 25
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 24
- 239000003792 electrolyte Substances 0.000 claims description 21
- -1 3,4-dihydroxy-α-[(methylamino) methyl] benzyl Chemical group 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000007254 oxidation reaction Methods 0.000 claims description 17
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 16
- 230000003647 oxidation Effects 0.000 claims description 16
- 239000001632 sodium acetate Substances 0.000 claims description 16
- 235000011054 acetic acid Nutrition 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 12
- 239000003011 anion exchange membrane Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- XSXCZNVKFKNLPR-UHFFFAOYSA-N carbazochrome Chemical compound NC(=O)NN=C1C(=O)C=C2N(C)CC(O)C2=C1 XSXCZNVKFKNLPR-UHFFFAOYSA-N 0.000 claims description 7
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 239000004280 Sodium formate Substances 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 claims description 3
- 235000019254 sodium formate Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 26
- RPHLQSHHTJORHI-UHFFFAOYSA-N Adrenochrome Chemical compound O=C1C(=O)C=C2N(C)CC(O)C2=C1 RPHLQSHHTJORHI-UHFFFAOYSA-N 0.000 description 23
- 239000013078 crystal Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- 239000000463 material Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000005868 electrolysis reaction Methods 0.000 description 12
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 239000010439 graphite Substances 0.000 description 9
- 229910002804 graphite Inorganic materials 0.000 description 9
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- UJTTUOLQLCQZEA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(4-hydroxybutyl)carbamate Chemical compound C1=CC=C2C(COC(=O)NCCCCO)C3=CC=CC=C3C2=C1 UJTTUOLQLCQZEA-UHFFFAOYSA-N 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- PAYGMRRPBHYIMA-UHFFFAOYSA-N sodium;trihydrate Chemical compound O.O.O.[Na] PAYGMRRPBHYIMA-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- YADSGOSSYOOKMP-UHFFFAOYSA-N dioxolead Chemical compound O=[Pb]=O YADSGOSSYOOKMP-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- REAVCZWUMGIGSW-UHFFFAOYSA-M 4-methylbenzenesulfonate;tetrabutylazanium Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.CCCC[N+](CCCC)(CCCC)CCCC REAVCZWUMGIGSW-UHFFFAOYSA-M 0.000 description 1
- QKFFSWPNFCXGIQ-UHFFFAOYSA-M 4-methylbenzenesulfonate;tetraethylazanium Chemical compound CC[N+](CC)(CC)CC.CC1=CC=C(S([O-])(=O)=O)C=C1 QKFFSWPNFCXGIQ-UHFFFAOYSA-M 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000012028 Fenton's reagent Substances 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- WLLGXVUJGZVOAE-UHFFFAOYSA-N [F].[F].[F].[F].C(CCC)[N+](CCCC)(CCCC)CCCC Chemical compound [F].[F].[F].[F].C(CCC)[N+](CCCC)(CCCC)CCCC WLLGXVUJGZVOAE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229960004353 carbazochrome sodium sulfonate Drugs 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- VZDYWEUILIUIDF-UHFFFAOYSA-J cerium(4+);disulfate Chemical compound [Ce+4].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O VZDYWEUILIUIDF-UHFFFAOYSA-J 0.000 description 1
- 229910000355 cerium(IV) sulfate Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MGZTXXNFBIUONY-UHFFFAOYSA-N hydrogen peroxide;iron(2+);sulfuric acid Chemical compound [Fe+2].OO.OS(O)(=O)=O MGZTXXNFBIUONY-UHFFFAOYSA-N 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 1
- BWILYWWHXDGKQA-UHFFFAOYSA-M potassium propanoate Chemical compound [K+].CCC([O-])=O BWILYWWHXDGKQA-UHFFFAOYSA-M 0.000 description 1
- 235000010332 potassium propionate Nutrition 0.000 description 1
- 239000004331 potassium propionate Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003962 selenoxides Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HLFCZZKCHVSOAP-WXIWBVQFSA-M sodium;(5e)-5-(carbamoylhydrazinylidene)-1-methyl-6-oxo-2,3-dihydroindole-2-sulfonate Chemical compound [Na+].NC(=O)N\N=C/1C(=O)C=C2N(C)C(S([O-])(=O)=O)CC2=C\1 HLFCZZKCHVSOAP-WXIWBVQFSA-M 0.000 description 1
- HLFCZZKCHVSOAP-UHFFFAOYSA-M sodium;5-(carbamoylhydrazinylidene)-1-methyl-6-oxo-2,3-dihydroindole-2-sulfonate Chemical compound [Na+].NC(=O)NN=C1C(=O)C=C2N(C)C(S([O-])(=O)=O)CC2=C1 HLFCZZKCHVSOAP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003866 tertiary ammonium salts Chemical class 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- KBLZDCFTQSIIOH-UHFFFAOYSA-M tetrabutylazanium;perchlorate Chemical compound [O-]Cl(=O)(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC KBLZDCFTQSIIOH-UHFFFAOYSA-M 0.000 description 1
- WGHUNMFFLAMBJD-UHFFFAOYSA-M tetraethylazanium;perchlorate Chemical compound [O-]Cl(=O)(=O)=O.CC[N+](CC)(CC)CC WGHUNMFFLAMBJD-UHFFFAOYSA-M 0.000 description 1
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 다음의 일반식,로 표시되는 아드레노크롬 모노세미카바존(즉, 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌)에 대한 신규이고 효유적인 제조방법에 관한 것이다.The present invention is the following general formula, Novel and effective against adrenochrome monosemicabazone (ie 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole) represented by It relates to a manufacturing method.
본 발명의 목적 화합물(I)은 지혈제로서 유용할 뿐만 아니라, 지혈제로서 널리 사용되는 카바조크롬 소디움술포네이트(즉, 1-메틸-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌-2-술폰산소디움염) 합성의 중간체로서도 유용하다.The compound (I) of the present invention is not only useful as a hemostatic agent, but also widely used as a hemostatic agent, carbazochrome sodiumsulfonate (i.e., 1-methyl-5-semicarbazono-6-oxo-2, 3, 5, 6-tetrahydroindole-2-sulfonic acid sodium salt) is also useful as an intermediate of the synthesis.
아드렌날린을 각종의 산화제로 산화시킨후, 세미카바자이드로 처리하여 상기의 화합물(Ⅰ)을 제조하는 몇가지 제조방법이 공지되어 있으며, 상기 산화제의 예로서는, 포타슘 페리시아나이드(저널 오브 케미칼 소사이어티, P, 2248-2252, 1951), 이산화납(내아춰, 166권, P, 831-832, 1950), 이산화마그네슘(케미칼어브스트랙트, 4권, 4533, 1950), 머큐리 할라이드(케칼 어브스트랙트, 44권, 2580, 1950), 세릭설페이트(케미칼 어브스트랙트, 42권, 5075, 1948), 펜톤시약(Fenton's reagent : 저널 오브 바아올러지칼 케미스트리, 220권, P, 227-235, 1956), 다이페닉셀레녹사이드(신테시스, P, 172, 1973)가 있다. 그러나 이러한 산화방법들은 공업적인 방법으로서는 유해한 부산물을 산출한다는 중대한 결점을 갖고 있다.Several preparation methods for preparing the above compound (I) by oxidizing adrenergic with various oxidants and then treating with semicarbazide are known. Examples of the oxidizing agent include potassium ferricyanide (Journal of Chemical Society, P, 2248-2252, 1951), lead dioxide (Naeji, 166, P, 831-832, 1950), magnesium dioxide (Chemical Abtract, Vol. 4, 4533, 1950), Mercury Halide (Chemical Abtract) , 44, 2580, 1950), cericsulfate (Chemical Abtract, 42, 5075, 1948), Fenton's reagent (Journal of Baral Chemical Chemistry, 220, P, 227-235, 1956) , Diphenic selenoxide (synthesis, P, 172, 1973). However, these oxidation methods have the serious drawback of producing harmful by-products as industrial methods.
또한, 아드레날린을 소디움퍼설페이트로 산화시켜서, 유해한 부산물을 전혀 산출시키지 않는 방법(저널 오브 케미칼 소사이어티 P, 1276-1282, 1950)이 공지되어 있다.It is also known to oxidize adrenaline with sodium persulfate to yield no harmful byproducts (Journal of Chemical Society P, 1276-1282, 1950).
그러나 상기의 산화방법은 생성물의 수율 및 순도에 결함을 갖고 있다. 이러한 상황하에서 경제적이고도 높은 순도를 갖는 아드레노크롬 모노세미카바존(Ⅰ)에 대한 제조방법의 개발필요성이 증대되어 왔다.However, the above oxidation method has a defect in yield and purity of the product. Under these circumstances, the need for development of a manufacturing method for adrenochrome monosemicabazone (I), which is economical and of high purity, has been increased.
한편 전자를 시약으로서 이용하는 전기분해법을 사용하여 유기화합물을 합성하는 방법이 유해한 부산물을 산출하지 않는 순수한 방법으로서 최근들어 주의를 끌고 있다.On the other hand, the method of synthesizing organic compounds using electrolysis using electrons as a reagent has recently attracted attention as a pure method that does not produce harmful by-products.
그러나 전기분해법은 일반적으로 반응을 완결시키는데 오랜 시간이 필요하고, 정전류 또는 정전압하에서 수행되어져야 한다.However, electrolysis generally requires a long time to complete the reaction and must be carried out under constant current or constant voltage.
따라서 이러한 물질은 전기분해 조건하에서는 불안정하기 때문에, 전기합성법은 공업적인 생산에는적합하지 못한 것으로 인식되어져 왔다. 화합물(Ⅰ)은 중간체인 아드레노크롬은 수용액 중에서 매우 불안정하여 실온에서 몇시간 이내에 루틴 또는 멜라닌과 같은 물질로 변하게 되며, 또한 수용액 중에서 산화되기 쉽다.Thus, since these materials are unstable under electrolysis conditions, the electrosynthesis method has been recognized as unsuitable for industrial production. Compound (I) is an intermediate, adrenochrome, which is very unstable in aqueous solution, and turns into a substance such as rutin or melanin within a few hours at room temperature, and is also easy to oxidize in aqueous solution.
따라서 화합물(Ⅰ)을 제조하는데 있어서, 아드레날린을 아드레노크롬으로 산화시키는 전기분해법은 전혀 이용되지 못하였다.Therefore, in preparing compound (I), no electrolysis method for oxidizing adrenergic to adrenochrome was used.
상기와 같은 상황하에서 아드레날린의 산화에 대한 광범위한 연구결과로서, 본 발명의 발명자들은 아드레노크롬이 염을 포함하는 수용액 중에서 안정하며, 전해 산화가 보조전해질을 포함하는 물 중에서 수행되어질때 그 결과로서 생성되는 아드레노크롬에 과도하게 산화되는 일 없이 아드레날린이 선택적으로 산화된다는 사실을 발견하고, 이에 입각하여 본 발명을 완성하였다.As a result of extensive research on the oxidation of adrenaline under such circumstances, the inventors of the present invention are stable as adrenochrome is in an aqueous solution containing a salt, and as a result, when electrolytic oxidation is carried out in water containing an auxiliary electrolyte, The present inventors have found that adrenaline is selectively oxidized without being excessively oxidized to adrenochrome, and thus, the present invention has been completed.
본 발명의 목적은 보조전해질이 포함된 물 속에서 아드레날린(Ⅱ) 즉 3, 4-다이하이드록시-α-[(메틸아미노]메틸]벤진알콜을 전해 산화시켜서, 아드레노크롬(Ⅲ), 즉 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 생성시키고, 이것과 세미카바자이드(Ⅳ)를 반응시켜서 이루어지는 아드레노크롬 모노세미카바존(Ⅰ), 즉 1-메틸-3-하이드록시-5-세미카바노노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌의 신규이고, 효율적인 제조방법을 제공하는 것이다.An object of the present invention is to adrenochrome (III), that is, by electrolytic oxidation of adrenaline (II) or 3, 4-dihydroxy-α-[(methylamino] methyl] benzin alcohol in water containing an auxiliary electrolyte Adrenochrome monosemicabazone formed by producing 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, 6-tetrahydroindole and reacting this with semicarbazide (IV) (I), i.e., a novel and efficient method for preparing 1-methyl-3-hydroxy-5-semicabanono-6-oxo-2, 3, 5, 6-tetrahydroindole.
본 발명에 따른 반응은 다음과 같다.The reaction according to the present invention is as follows.
본 발명의 제조방법을 이하에서 더욱 상세히 설명하기로 한다.The manufacturing method of the present invention will be described in more detail below.
본 발명의 첫번째 단계인 전해산화는 음극액과 양극액 모두 또는 음극액에 보조전해질이 첨가되고, 물이 용매로서 사용되며, 양극과 음극이 음이온 교환막과 같은 격막에 의해서 분리되도록 설치된 전해조에 전류를 공급하여 수행된다.In the first step of the present invention, the electrolytic oxidation is performed by adding an auxiliary electrolyte to both the catholyte and the anolyte or catholyte, using water as a solvent, and applying a current to an electrolytic cell installed so that the anode and the cathode are separated by a diaphragm such as an anion exchange membrane. It is done by feeding.
본 발명에서 사용되는 전해조는 H-형 전해조, 필터프레스형 전해조와 같은 각종 형태의 전해조가 사용될 수 있다.As the electrolyzer used in the present invention, various types of electrolyzers such as an H-type electrolyzer and a filter press-type electrolyzer may be used.
상기의 전해조는 전해질의 작용을 견디어 낼 수 있는 소재로 제조되어야 한다. 상기의 전해조는 격막에 의하여 양극실과음극실로 분리되어 있어야 한다.The electrolyzer should be made of a material that can withstand the action of the electrolyte. The electrolytic cell should be separated into the anode chamber and the cathode chamber by the diaphragm.
공업적인 제조에 있어서는 다수의 양극판과 음극판이 서로 대향하여 병렬로 배치되고, 상기의 양극판과 음극판 사이에 격막이 게재되어 있는 필터프레스형(filter press type) 전해조를 사용하는 것이 바람직하다. 예를들면, 본 발명의 전해산화에 사용되는 양극으로서는 흑연전극, 백금전극, 납전극등을 적절히 사용할 수가 있으며 음극으로서는 흑연적극, 백금전극, 납전극, 스테인레스강전극등을 적절히 사용할 수 있다.In industrial production, it is preferable to use a filter press type electrolytic cell in which a plurality of positive electrode plates and negative electrode plates are arranged in parallel to each other and a diaphragm is disposed between the positive electrode plates and the negative electrode plates. For example, a graphite electrode, a platinum electrode, a lead electrode, etc. can be used suitably as an anode used for the electrolytic oxidation of this invention, and a graphite electrode, a platinum electrode, a lead electrode, a stainless steel electrode etc. can be used suitably as a cathode.
양극실과 음극실로 분리시키는 격박은 이온교환막, 세라믹막, 셀로판 또는 신터글래스(sintered glass)와 같은 막이 사용되며, 이중에서도 음이온 교환막이 바람직하다.Separation between the anode chamber and the cathode chamber is used such as an ion exchange membrane, a ceramic membrane, cellophane or sintered glass, and an anion exchange membrane is preferable.
음극액 또는 양극액 모두 또는 음극에 첨가되는 보조전해질의 예로서는 소디움포메이트, 포타슘 포메이트, 소디움 아세테이트, 포타슘 아세테이트, 리튬아세테이트, 소디움 프로피오네이트, 포타슘 프로피오네이트, 소디움 사이트레이트, 포타슘 사이트레이트와 같은 유기화합물의 알칼리 금속염, 리튬클로라이드, 소디움클로라이드, 포타슘 클로라이드, 소디움설페이트, 포타슘설페이트, 소디움하이드로젠 설페이트, 포타슘 하이드로젠 설페이트, 소디움 하이드로젠 포스페이트, 소디움 디아히드로젠 포스페이트, 포타슘 하이드로젠 포스페이트, 포타슘 디하이드로젠 포스페이트, 소디움 보레이트, 포타슘 보레이트, 소디움 퍼클로레이트, 포타슘 퍼클로레이트와 같은 무기화합물의 알칼리 금속염, 테트라메틸암모늄 클로라이드, 테트라메틸암모늄 토실레이트, 테트라메틸암모늄클로라이드, 테트라메틸암모늄 브로마이드, 테트라에틸암모늄 토실레이트, 테트라에틸암모늄 퍼클로레이트, 테트라부틸암모늄 클로라이드, 테트라부틸암모늄 브로마이드, 테트라부틸암모늄 토실레이트, 테트라부틸암모늄 퍼클로레이트, 테트라부틸암모늄 테트라플루오로보레이트와 같은 제 3 암모늄염이 있다.Examples of the auxiliary electrolyte added to both the catholyte or the anolyte or to the cathode include sodium formate, potassium formate, sodium acetate, potassium acetate, lithium acetate, sodium propionate, potassium propionate, sodium citrate, potassium citrate and Alkali metal salts of the same organic compounds, lithium chloride, sodium chloride, potassium chloride, sodium sulfate, potassium sulfate, sodium hydrogen sulfate, potassium hydrogen sulfate, sodium hydrogen phosphate, sodium diahydrogen phosphate, potassium hydrogen phosphate, potassium di Alkali metal salts of inorganic compounds such as hydrogen phosphate, sodium borate, potassium borate, sodium perchlorate, potassium perchlorate, tetramethylammonium chloride, tetramethylammonium Silate, tetramethylammonium chloride, tetramethylammonium bromide, tetraethylammonium tosylate, tetraethylammonium perchlorate, tetrabutylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium tosylate, tetrabutylammonium perchlorate, tetrabutylammonium tetrafluor There is a tertiary ammonium salt such as bororate.
상기의 보조전해질은 단독으로 또는 혼합물로서 사용된다.The above secondary electrolytes are used alone or as a mixture.
상기에서 바람직한 것은 유기화합물의 알칼리 금속염이며, 더욱 바람직하게는 소디움 아세테이트이다.Preferred above are alkali metal salts of organic compounds, more preferably sodium acetate.
보조전해질의 양은 양극액과 음극액에서 서로 다르다.The amount of auxiliary electrolyte is different in the anolyte and catholyte.
예를들면 소디움아세테이트가 보조전해질로서 사용될 때 양극액중의 아드레날린(Ⅱ)의 1몰에 대하여 0-0.4몰의 양이 적절하며, 바람직하게는 0-0.5몰의 양이다.For example, when sodium acetate is used as the auxiliary electrolyte, an amount of 0-0.4 mole is suitable for 1 mole of adrenaline (II) in the anolyte, and preferably 0-0.5 mole.
상기에서 언급한 필터프레스형 전해조가 사용될 경우, 음극액의 일부 성분이 격막을 통하여 양극액내로 들어갈 수 있기 때문에 양극액에 대한 보조전해질의 첨가는 필수적인 것은 아니다.When the filter press-type electrolytic cell mentioned above is used, addition of the auxiliary electrolyte to the anolyte is not essential because some components of the catholyte may enter the anolyte through the diaphragm.
반면에 음극액에는 아드레날린(Ⅱ)의 1몰당 보조전해질을 적당하게는 0.5몰 이상, 바람직하게는 0.5-60몰 그리고 더욱 바람직하게는 0.5-25몰을 첨가한다.On the other hand, the catholyte is preferably added at least 0.5 mol, preferably 0.5-60 mol, and more preferably 0.5-25 mol of the auxiliary electrolyte per mol of adrenaline (II).
상기의 전해 산화는 양극액중에 산을 존재시킨 상태에서 수행하는 것이 효과적이다.The electrolytic oxidation is effective to be carried out in the presence of acid in the anolyte solution.
이러한 산의 예로서는 포름산, 초산, 프로피온산, 구연산과 같은 유기산을 들 수 있으며, 이중에서 초산이 바람직하다.Examples of such acids include organic acids such as formic acid, acetic acid, propionic acid and citric acid, of which acetic acid is preferred.
상기와 같은 산은 아드레날린(Ⅱ)의 1몰에 대하여 0.1-10.0몰의 양, 바람직하게는 1.0-2.0몰의 양으로 사용된다.Such acid is used in an amount of 0.1-10.0 moles, preferably 1.0-2.0 moles, per 1 mole of adrenaline (II).
본 발명의 전해산화에 있어서, 아드레날린(Ⅱ), 물 그리고 필요에 따라 포함될 수도 있는 보조전해질을 포함하는 수용액인 양극액과 물과 보조전해질을 포함하는 수용액인 음극액은 각각 전해조내의 양극실과 음극실에 위치한다.In the electrolytic oxidation of the present invention, the anolyte which is an aqueous solution containing adrenaline (II), water and an auxiliary electrolyte which may be included if necessary, and the catholyte which is an aqueous solution containing water and an auxiliary electrolyte are respectively an anode chamber and an anode chamber in an electrolytic cell. Located in
그후 상기의 전해조에 전류를 통과시키게 된다.Thereafter, a current is passed through the electrolyzer.
양극액중의 아드레날린(Ⅱ)의 농도는 0.5-3W/W%가 적당하다.The concentration of adrenaline (II) in the anolyte is appropriately 0.5-3W / W%.
공급되는 전류의 밀도는 적절히 선택될 수 있으나, 바람직한 것은 약 0.1-50㎃/㎠이다.The density of the current to be supplied may be appropriately selected, but is preferably about 0.1-50 mA / cm 2.
상기의 전해산화는 일반적으로 0-20℃에서 수행되며, 바람직하게는 1-10℃이다.The electrolytic oxidation is generally carried out at 0-20 占 폚, preferably 1-10 占 폚.
반응시간은 사용되는 아드레날린(Ⅱ)의 양, 공급되는 전류의 양등에 따라 달라지게 되지만, 일반적으로는 10시간 또는 그 이하가 바람직하다.The reaction time depends on the amount of adrenaline (II) used, the amount of current supplied, and the like, but generally 10 hours or less is preferable.
상기에서 설명한 바와같이하여 전해산화를 수행함에 있어서 아드레노크롬(Ⅲ)은 양극액중에 생성되게 되며, 이것을 분리하지 않은 상태 그대로 다음 단계에서 처리하게 된다.In the electrolytic oxidation as described above, adrenochrome (III) is produced in the anolyte solution, and is treated in the next step without being separated.
본 발명은 두번째 단계에서의 아드레노크롬(Ⅲ)와 세미카바자이드의 반응은 전해산화반응이 종결된 양극액에 세미카바자이드를 가하는 것으로 용이하게 실시할 수 있다.The reaction of the adrenochrome (III) and the semicarbazide in the second step can be easily carried out by adding semicarbazide to the anolyte solution in which the electrolytic oxidation reaction is terminated.
상기의 세미카바자이드(Ⅳ)는 염산염의 형태로 사용하는 것이 효과적이다. 또한 반응온도는 5-20℃가 바람직하다.It is effective to use the semicarbazide (IV) in the form of hydrochloride. Moreover, as for reaction temperature, 5-20 degreeC is preferable.
결과로서 얻어지는 화합물(Ⅰ)은 알칼리 수용액(예를들면, 소디움 카보네이트 수용액)이나 산성수용액(예를들면, 1N 염산)을 반응혼합물에 가하여 pH를 5.0-5.3으로 조절하여 모으게 되며, 그 후 여과 또는 통상적인 방법으로 처리하게 된다.The resulting compound (I) is collected by adjusting the pH to 5.0-5.3 by adding an aqueous alkali solution (e.g., an aqueous sodium carbonate solution) or an acidic aqueous solution (e.g., 1N hydrochloric acid) to the reaction mixture, followed by filtration or The treatment is done in the usual way.
본 발명의 제조방법에 의하여면, 어떠한 유해한 물질이나 부산물도 생성하지 않으며, 양호한 수율로서 높은 순도를 갖는 화합물(Ⅰ)을 산출하므로, 화합물(Ⅰ)에 대한 우수한 공업적 제조방법이다.According to the production method of the present invention, no harmful substances or by-products are produced, and compound (I) having high purity in a good yield is produced, which is an excellent industrial production method for compound (I).
본 발명의 제조방법을 다음의 실시예를 통하여 더욱 상세히 설명하기로 한다.The manufacturing method of the present invention will be described in more detail with reference to the following examples.
그러나 이것은 본 발명을 제한하는 것은 아니다.However, this does not limit the present invention.
또한, 본 발명의 중간체인 아드레노크롬(Ⅲ)와 최종산물인 아드레노크롬 모노세미카바존(Ⅰ)은 다음과 같이 양성이온(zwitterion)의 형태로 표시될 수 있다.In addition, adrenochrome (III), an intermediate of the present invention, and adrenochrome monosemicabazone (I), a final product, may be represented in the form of zwitterion as follows.
그러나 본 명세서 중에서는 상기에서 언급한 바와 같이 일반식(Ⅰ)과 (Ⅲ)의 구조에 입각하여 이들 화합물을 명명하였다.However, in the present specification, as mentioned above, these compounds are named based on the structures of the general formulas (I) and (III).
[실시예 1]Example 1
3, 4-다이하이드록시-α-[(메틸아미노)메틸]벤질알콜(즉 아드레날린) 1.37g, 소디움 아세테이트·트리하이드레이트 2.04g, 초산 1.72ml과 물 137ml의 혼합물을 양극과 음극이 음이온 교환막으로 분리되도록 설치된 전해조내의 양극실내에 넣었다.A mixture of 1.37 g of 3,4-dihydroxy-α-[(methylamino) methyl] benzyl alcohol (i.e., adrenaline), 2.04 g of sodium acetate and trihydrate, 1.72 ml of acetic acid and 137 ml of water was used as an anion exchange membrane. It was placed in the anode chamber in the electrolytic cell installed to be separated.
또한 소디움 아세테이트·트리하이드레이트 2.04g과 물 137ml의 혼합물을 음극실에 넣었다.In addition, a mixture of 2.04 g of sodium acetate trihydrate and 137 ml of water was placed in a cathode chamber.
흑연전극(4×5㎠)을 각각의 양극실내에 평행으로 장치하였다.Graphite electrodes (4 x 5 cm 2) were placed in parallel in each anode chamber.
전해는 격렬한 교반하에 총전류가 이론양의 75%에 도달할 때까지의 1℃에서 102㎃의 정전류로 그 후에는 전류를 75㎃의 정전류가 되도록 낮추어서 수행하였다.The electrolysis was carried out under vigorous stirring with a constant current of 102 mA at 1 ° C. until the total current reached 75% of the theoretical amount, followed by lowering the current to a constant current of 75 mA.
이론양의 전류가 통과된 후, 양극액중에 생성된 아드레노크롬 즉 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 취하여 세미카바자이드 염산염 1.0g과 혼합하였다.After passing the theoretical amount of current, semicarbazide is obtained by taking adrenochrome produced in the anolyte, namely, 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, and 6-tetrahydroindole. Mix with 1.0 g hydrochloride.
상기의 혼합액을 격렬한 교반하에 소디움 카보네이트 포화용액으로 5.2로 조절하고, 8℃에서 하룻반동안 교반하였다.The mixture was adjusted to 5.2 with saturated sodium carbonate solution under vigorous stirring and stirred at 8 ° C. for one and a half hours.
침전된 결정을 여과하여 모으고, 10ml의 얼음물로 세정한 후, 진공건조하여 붉은 결정의 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌(즉 아드레노크롬 모노세미카바존)을 얻었다. 수율 : 1.30g(74.4%)The precipitated crystals were collected by filtration, washed with 10 ml of ice water, and then dried in vacuo to give 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetra as red crystals. Hydroindole (ie, adrenochrome monosemicabazone) was obtained. Yield: 1.30 g (74.4%)
NMR(d6-DMSO)δ : 3.01(s, 3H), 3.33-4.2(m, 2H), 4.8-5.2(m, 1H), 5.38(s, 1H), 5.75(d, 1H, J=5Hz), 6.72(s, 1H), 7.02(broad, 2H), 14.71(broad, 1H)NMR (d 6 -DMSO) δ: 3.01 (s, 3H), 3.33-4.2 (m, 2H), 4.8-5.2 (m, 1H), 5.38 (s, 1H), 5.75 (d, 1H, J = 5Hz ), 6.72 (s, 1H), 7.02 (broad, 2H), 14.71 (broad, 1H)
[실시예 2]Example 2
흑연전극대신에 백금전극(4×5㎠)을 사용하는 것을 제외하고는, 실시예 1에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 1, except that a platinum electrode (4 x 5 cm 2) was used instead of the graphite electrode.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.19g을 얻었다. 수율 : 67.2%1.19 g of 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole, which are red crystals, were obtained. Yield: 67.2%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 3]Example 3
양극액의 내부온도를 1℃ 대신에 5℃로 유지하는 것을 제외하고는, 실시예 1에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 1, except that the internal temperature of the anolyte solution was maintained at 5 ° C instead of 1 ° C.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.20g을 얻었다. 수율 : 72.9%1.20 g of 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole as red crystals were obtained. Yield: 72.9%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 4]Example 4
양극액의 내부온도를 1℃ 대신에 10℃로 유지하는 것을 제외하고는, 실시예 1에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 1, except that the internal temperature of the anolyte solution was maintained at 10 ° C instead of 1 ° C.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.26g을 얻었다. 수율 : 71.2%1.26 g of 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole as red crystals were obtained. Yield: 71.2%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 5]Example 5
소디움아세테이트 대신에 전해질로서 포타슘 아세테이트 1.47g을 사용하는 것을 제외하고는, 실시예 1에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 1, except that 1.47 g of potassium acetate was used as the electrolyte instead of sodium acetate.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.31g을 얻었다. 수율 : 74.0%1.31 g of 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole, which are red crystals, were obtained. Yield: 74.0%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 6]Example 6
전해질로서 소디움아세테이트와 초산 대신에 소디움포메이트 1.02g과 포름산 0.69g을 각각 사용하는 것을 제외하고는, 실시예 1에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 1, except that 1.02 g of sodium formate and 0.69 g of formic acid were used instead of sodium acetate and acetic acid as the electrolyte.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.17g을 얻었다. 수율 : 66.1%1.17 g of red crystals 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole were obtained. Yield: 66.1%
생성물의 물리화학적 성질은 실시예 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 7]Example 7
3, 4-다이하이드록시-α-[(메틸아미노)메틸]벤질알콜, 2.06g, 소디움아세테이트·트리하이드레이트 3.06g, 초산 2.58ml과 물 137ml의 혼합물을 양극과 음극이 음이온 교환막으로 분리되도록 설치된 전해조내의 양극실내에 넣었다.3,4-dihydroxy-α-[(methylamino) methyl] benzyl alcohol, 2.06 g, sodium acetate trihydrate 3.06 g, a mixture of 2.58 ml of acetic acid and 137 ml of water were installed so that the positive and negative electrodes were separated by an anion exchange membrane. It was placed in the anode chamber in the electrolytic cell.
또한 소디움아세테이트·트리하이드레이트 3.06g과 물 137ml의 혼합물을 음극실에 넣었다.A mixture of 3.06 g of sodium acetate trihydrate and 137 ml of water was placed in a cathode chamber.
흑연전극(4×5㎠)을 각각의 양극실내에 평행으로 장치하였다.Graphite electrodes (4 x 5 cm 2) were placed in parallel in each anode chamber.
전해는 격렬한 교반하에 총전류가 이론양의 75%에 도달할 때까지의 1℃에서 153㎃의 정전류로 그 후에는 전류를 75㎃의 정전류가 되도록 낮추어서 수행하였다.The electrolysis was carried out under vigorous stirring with a constant current of 153 mA at 1 ° C. until the total current reached 75% of the theoretical amount, followed by lowering the current to a 75 mA constant current.
이론양의 전류가 통과된후, 양극액중에 생성된 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 취하여 세미카바자이드 염산염 1.5g과 혼합하였다.After passing the theoretical current, 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, 6-tetrahydroindole produced in the anolyte solution was taken and 1.5 g of semicarbazide hydrochloride was added. Mixed.
상기의 혼합액을 실시예 1에서와 같은 방법으로 처리하여, 붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.97g을 얻었다. 수율 : 74.2%The mixture was treated in the same manner as in Example 1 to give red crystals 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole 1.97 g was obtained. Yield: 74.2%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 8]Example 8
3, 4-다이하이드록시-α-[(메틸아미노)메틸]벤질알콜, 2.74g, 소디움아세테이트·트리하이드레이트 4.08g, 초산 3.44ml과 물 137ml의 혼합물을 양극과 음극이 음이온 교환막으로 분리되도록 설치된 전해조내의 양극실내에 넣었다.3,4-Dihydroxy-α-[(methylamino) methyl] benzyl alcohol, 2.74 g, sodium acetate trihydrate 4.08 g, a mixture of 3.44 ml of acetic acid and 137 ml of water were installed so that the positive and negative electrodes were separated by an anion exchange membrane. It was placed in the anode chamber in the electrolytic cell.
또한 소디움아세테이트·트리하이드레이트 4.08g과 물 137ml의 혼합물을 넣었다.A mixture of 4.08 g of sodium acetate and trihydrate and 137 ml of water was added thereto.
흑연전극(5×8㎠)을 각각의 양극실내에 평행으로 장치하였다.Graphite electrodes (5 x 8 cm 2) were placed in parallel in each anode chamber.
전해는 격렬한 교반하에 총전류가 이론양의 75%에 도달할 때까지의 1℃에서 204㎃의 정전류로 그 후에는 전류를 100㎃의 정전류가 되도록 낮추어서 수행하였다.Electrolysis was carried out under vigorous stirring at a constant current of 204 mA at 1 ° C. until the total current reached 75% of the theoretical amount, followed by lowering the current to a constant current of 100 mA.
이론양의 전류가 통과된후, 양극액중에 생성된 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 취하여 세미카바자이드 염산염 2.0g과 혼합하였다.After passing the theoretical amount of current, take 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, 6-tetrahydroindole produced in the anolyte solution, and 2.0 g of semicarbazide hydrochloride. Mixed.
상기의 혼합액을 실시예 1에서와 같은 방법으로 처리하여, 붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 2.90g을 얻었다. 수율 : 82.2%The mixture was treated in the same manner as in Example 1 to give red crystals 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole 2.90 g was obtained. Yield: 82.2%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 9]Example 9
양극액의 내부온도를 1℃ 대신에 5℃로 유지하는 것을 제외하고는, 실시예 8에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 8 except that the internal temperature of the anolyte solution was maintained at 5 ° C instead of 1 ° C.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 2.59g을 얻었다. 수율 : 73.4%2.59 g of 1-methyl-3-hydroxy-5-semicarbazono-6-oxo-2, 3, 5, 6-tetrahydroindole as red crystals were obtained. Yield: 73.4%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 10]Example 10
3, 4-다이하이드록시-α-[(메틸아미노)메틸]벤질알콜, 1.37g, 소디움아세테이트 1.23g, 초산 1.72ml과 물 137ml의 혼합물을 양극과 음극이 음이온 교환막으로 분리되도록 설치된 전해조내의 양극실내에 넣었다.3, 4-dihydroxy-α-[(methylamino) methyl] benzyl alcohol, 1.37 g, sodium acetate, 1.23 g, a mixture of 1.72 ml of acetic acid and 137 ml of water, the anode in the electrolytic cell installed to separate the anode and cathode by an anion exchange membrane Put it indoors.
또한 소디움아세테이트 1.23g과 물 137ml의 혼합물을 넣었다. 흑연전극(4×5㎠)을 각각의 양극실내에 평행으로 장치하였다.Also, a mixture of 1.23 g of sodium acetate and 137 ml of water was added thereto. Graphite electrodes (4 x 5 cm 2) were placed in parallel in each anode chamber.
전해는 격렬한 교반하에 총전류가 이론양의 75%에 도달할 때까지의 100㎃의 정전류로 그 후에는 전류를 75㎃의 정전류가 되도록 낮추어서 수행하였다.Electrolysis was carried out under vigorous stirring with a constant current of 100 mA until the total current reached 75% of the theoretical amount, after which the current was lowered to a constant 75 mA.
양극액의 내부온도는 전해시키는 동안 1℃로 유지하였다.The internal temperature of the anolyte was kept at 1 ° C. during electrolysis.
이론양의 전류가 통과된후, 양극액중에 생성된 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 취하여 세미카바자이드 염산염 1.0g과 혼합하였다.After passing the theoretical current, 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, 6-tetrahydroindole produced in the anolyte solution was taken and 1.0 g of semicarbazide hydrochloride was added. Mixed.
상기의 혼합액을 실시예 1에서와 같은 방법으로 처리하여, 붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.39g을 얻었다. 수율 : 78.5%The mixed solution was treated in the same manner as in Example 1 to give red crystals 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole 1.39 g was obtained. Yield: 78.5%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 11]Example 11
양극액의 내부온도를 1℃ 대신에 5℃로 유지하는 것을 제외하고는, 실시예 10에서와 같은 방법으로 반응시켰다.The reaction was carried out in the same manner as in Example 10 except that the internal temperature of the anolyte solution was maintained at 5 ° C instead of 1 ° C.
붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노- 6-옥소-2, 3, 5, 6-테트라하이드로인돌 1.37g을 얻었다. 수율 : 77.4%1.37 g of 1-methyl-3-hydroxy-5-semicarbazono-6-oxo-2, 3, 5, 6-tetrahydroindole, which are red crystals, were obtained. Yield: 77.4%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 12]Example 12
3, 4-다이하이드록시-α-[(메틸아미노)메틸]벤질알콜, 2.06g, 소디움아세테이트 1.85g, 초산 2.58ml과 물 137ml의 혼합물을 양극과 음극이 음이온 교환막으로 분리되도록 설치된 전해조내의 양극실내에 넣었다.3, 4-dihydroxy-α-[(methylamino) methyl] benzyl alcohol, 2.06 g, sodium acetate, 1.85 g, a mixture of 2.58 ml of acetic acid and 137 ml of water, the positive electrode and the negative electrode in an electrolytic cell installed to separate the negative electrode with an anion exchange membrane. Put it indoors.
또한 소디움아세테이트 1.85g과 물 137ml의 혼합물을 넣었다. 흑연전극(4×5㎠)을 각각의 양극실내에 평행으로 장치하였다. 전해는 격렬한 교반하에 총전류가 이론양의 75%에 도달할 때까지의 150㎃의 정전류로 그 후에는 전류를 112㎃의 정전류가 되도록 낮추어서 수행하였다.In addition, a mixture of 1.85 g of sodium acetate and 137 ml of water was added thereto. Graphite electrodes (4 x 5 cm 2) were placed in parallel in each anode chamber. The electrolysis was carried out under vigorous stirring with a constant current of 150 mA until the total current reached 75% of the theoretical amount, after which the current was lowered to a constant current of 112 mA.
양극액의 내부온도는 전해시키는 동안 1℃로 유지하였다.The internal temperature of the anolyte was kept at 1 ° C. during electrolysis.
이론양의 전류가 통과된후, 양극액중에 생성된 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 취하여 세미카바자이드 염산염 1.5g과 혼합하였다.After passing the theoretical current, 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, 6-tetrahydroindole produced in the anolyte solution was taken and 1.5 g of semicarbazide hydrochloride was added. Mixed.
상기의 혼합액을 실시예 1에서와 같은 방법으로 처리하여, 붉은색 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 2.11g을 얻었다. 수율 : 79.4%The mixture was treated in the same manner as in Example 1 to give red crystals, 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole 2.11 g was obtained. Yield: 79.4%
생성물의 물리화학적 성질을 실시에 1에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 1.
[실시예 13]Example 13
장치로서는 음이온 교환막으로 분리된 양극판과 음극판(각각 14×28.5㎠의 흑연판) 그리고 양극액과 음극액을 넣는 두개의 탱크가 설치된 필터프레스형 전해조를 사용하였다.As a device, a filter press type electrolyzer was used, in which a positive electrode plate and a negative electrode plate (14 × 28.5 cm 2 graphite plates, respectively) separated by an anion exchange membrane, and two tanks containing an anolyte and a catholyte were installed.
3, 4-다이하이드록시-α-[(메틸아미노)메틸]벤질알콜 즉 아드레날린 13.9g, 소디움아세테이트·트리하이드레이트 278.6g, 초산 11.7ml과 물 2500ml의 혼합물을 양극과 탱크에 넣고, 소디움아세테이트·트리하이드레이트 278.6g과 물 2830ml의 혼합액을 음극액 탱크에 넣었다.A mixture of 3,4-dihydroxy-α-[(methylamino) methyl] benzyl alcohol, that is, 13.9 g of adrenaline, 278.6 g of sodium acetate and trihydrate, 11.7 ml of acetic acid, and 2500 ml of water was placed in a positive electrode and a tank. A mixture of 278.6 g of trihydrate and 2830 ml of water was placed in a catholyte tank.
양극액과 음극액은 양자 모두 탱크와 전해조 사이를 순환시키게되며, 전류는 초기에는 8.0A로 하고, 그 후에는 생성물(아드레노크롬)의 과도한 산화가 일어나지 않을 정도의 전류가 되도록 점차적으로 낮추어서 이론양의 전류가 모두 통과될 때까지 이러한 상태로 하였다.Both anolyte and catholyte are circulated between the tank and the electrolyzer, the current is initially 8.0A, and then gradually lowered to a current such that excessive oxidation of the product (adrenochrome) does not occur. This state was maintained until all the positive current passed.
양극액의 내부온도는 전해시키는 동안 3-8℃로 유지하였다.The internal temperature of the anolyte was maintained at 3-8 ° C. during electrolysis.
반응이 종료된 후, 양극액중 생성된 아드레노크롬, 즉 1-메틸-3-하이드록시-5, 6-다이옥소-2, 3, 5, 6-테트라하이드로인돌을 취하여, 세미카바자이드 염산염 7.4g과 혼합하였다.After the reaction was completed, the adrenochrome produced in the anolyte, i.e., 1-methyl-3-hydroxy-5, 6-dioxo-2, 3, 5, 6-tetrahydroindole, was taken to give semicarbazide hydrochloride. Mixed with 7.4 g.
상기의 혼합액을 격렬한 교반하에 소디움카보네이트 포화용액으로 pH5.2로 조절하고, 8℃에서 하룻밤 동안 교반하였다.The mixture was adjusted to pH 5.2 with saturated sodium carbonate solution under vigorous stirring and stirred at 8 ° C. overnight.
침전된 결정을 여과하여 모으고, 100ml의 얼음물로 세정한후, 붉은 결정의 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드라인돌(즉 아드레노크롬 모노세미카바존) 44.0g을 얻었다. 수율 : 91.1%The precipitated crystals were collected by filtration, washed with 100 ml of ice water, and then 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydrolinedol of red crystals. (That is, 44.0 g of adrenochrome monosemicabazone) was obtained. Yield: 91.1%
NMR(d6-DMSO)δ : 3.01(s, 3H), 3.33-4.2(m, 2H), 4.8-5.2(m, 1H), 5.38(s, 1H), 5.75(d, 1H, J=5Hz), 6.72(s, 1H), 7.02(broad, 2H), 14.71(broad, 1H)NMR (d 6 -DMSO) δ: 3.01 (s, 3H), 3.33-4.2 (m, 2H), 4.8-5.2 (m, 1H), 5.38 (s, 1H), 5.75 (d, 1H, J = 5Hz ), 6.72 (s, 1H), 7.02 (broad, 2H), 14.71 (broad, 1H)
[실시예 14]Example 14
음극액에 첨가되는 보조전해질인 소디움아세테이트·트리하이드레이트를 278.6g을 사용하는 대신에 13.9g을 사용하는 것을 제외하고는 실시에 13에서와 같은 방법으로 반응시켰다.Sodium acetate trihydrate, an auxiliary electrolyte added to the catholyte, was reacted in the same manner as in Example 13 except that 13.9 g was used instead of 278.6 g.
붉은 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 43.2g을 얻었다. 수율 : 89.4%43.2 g of red crystals 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole were obtained. Yield: 89.4%
생성물의 물리화학적 성질은 실시예 13에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 13.
[실시예 15]Example 15
음극액에 첨가되는 보조전해질인 소디움아세테이트·트리하이드레이트를 278.6g을 사용하는 대신에 55.7g을 사용하는 것을 제외하고는 실시에 13에서와 같은 방법으로 반응시켰다.Sodium acetate trihydrate, an auxiliary electrolyte added to the catholyte solution, was reacted in the same manner as in Example 13 except that 55.7 g was used instead of 278.6 g.
붉은 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 43.9g을 얻었다. 수율 : 90.9%43.9 g of red crystals, 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole were obtained. Yield: 90.9%
생성물의 물리화학적 성질은 실시예 13에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 13.
[실시예 16]Example 16
소디움아세테이트·트리하이드레이트를 양극액에 넣지 않고, 음극액에 첨가되는 보조전해질인 소디움아세테이트·트리하이드레이트를 278.6g을 사용하는 대신에 55.7g을 사용하는 것을 제외하고는 실시에 13에서와 같은 방법으로 반응시켰다.In the same manner as in Example 13, except that 55.7 g of sodium acetate trihydrate, which is an auxiliary electrolyte added to the catholyte, was used instead of 278.6 g of sodium acetate trihydrate without being added to the anolyte solution. Reacted.
붉은 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 43.8g을 얻었다. 수율 : 90.7%43.8 g of red crystals 1-methyl-3-hydroxy-5-semicabazono-6-oxo-2, 3, 5, 6-tetrahydroindole were obtained. Yield: 90.7%
생성물의 물리화학적 성질은 실시예 13에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 13.
[실시예 17]Example 17
실시예 13에서 양극액에 소디움아세테이트·트리하이드레이트 13.9g과 초산 11.7ml을 넣고 대신에 각기 111.4g과 117.0ml을 넘는 것을 제외하고는 실시예 13에서와 같은 방법으로 반응시켰다.In Example 13, 13.9 g of sodium acetate trihydrate and 11.7 ml of acetic acid were added to the anolyte solution, and the reaction was carried out in the same manner as in Example 13, except that 111.4 g and 117.0 ml were respectively exceeded.
붉은 결정인 1-메틸-3-하이드록시-5-세미카바조노-6-옥소-2, 3, 5, 6-테트라하이드로인돌 36.2g을 얻었다. 수율 : 74.9%36.2 g of 1-methyl-3-hydroxy-5-semicarbazono-6-oxo-2, 3, 5, 6-tetrahydroindole, which are red crystals, were obtained. Yield: 74.9%
생성물의 물리화학적 성질은 실시예 13에서 얻은 물질의 그것과 같았다.The physicochemical properties of the product were the same as those of the material obtained in Example 13.
Claims (17)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP78762 | 1982-05-10 | ||
JP7876282A JPS58194858A (en) | 1982-05-10 | 1982-05-10 | Method for producing tetrahydroindole derivatives |
JP109170 | 1982-06-24 | ||
JP57109170A JPS58225063A (en) | 1982-06-24 | 1982-06-24 | Preparation of tetrahydroindole derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
KR840004722A KR840004722A (en) | 1984-10-24 |
KR880001313B1 true KR880001313B1 (en) | 1988-07-23 |
Family
ID=26419827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019830002036A Expired KR880001313B1 (en) | 1982-05-10 | 1983-05-09 | Method for preparing tetrahydroindole derivative |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR880001313B1 (en) |
CH (1) | CH656878A5 (en) |
ES (1) | ES8502970A1 (en) |
IT (1) | IT1164213B (en) |
PT (1) | PT76665B (en) |
-
1983
- 1983-05-09 IT IT21003/83A patent/IT1164213B/en active
- 1983-05-09 ES ES522222A patent/ES8502970A1/en not_active Expired
- 1983-05-09 CH CH2533/83A patent/CH656878A5/en not_active IP Right Cessation
- 1983-05-09 KR KR1019830002036A patent/KR880001313B1/en not_active Expired
- 1983-05-09 PT PT76665A patent/PT76665B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT76665B (en) | 1986-01-10 |
KR840004722A (en) | 1984-10-24 |
IT1164213B (en) | 1987-04-08 |
ES522222A0 (en) | 1985-02-01 |
IT8321003A0 (en) | 1983-05-09 |
CH656878A5 (en) | 1986-07-31 |
ES8502970A1 (en) | 1985-02-01 |
IT8321003A1 (en) | 1984-11-09 |
PT76665A (en) | 1983-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4402804A (en) | Electrolytic synthesis of aryl alcohols, aryl aldehydes, and aryl acids | |
US4454012A (en) | Process for the preparation of methionine | |
KR880001313B1 (en) | Method for preparing tetrahydroindole derivative | |
US4778577A (en) | Process for preparing azetidine derivatives; and intermediates therein | |
US5266173A (en) | Process for preparing aromatic amine compounds and reducing agent therefor | |
US4517062A (en) | Process for the electrochemical synthesis of ethylene glycol from formaldehyde | |
US3980535A (en) | Process for producing sulfones | |
JPS6342713B2 (en) | ||
JPS59190378A (en) | Method for producing tetrahydroindole derivatives | |
US4797184A (en) | Process for producing 7,7,8,8-tetracyanoquinodimethane | |
JPH03107490A (en) | Preparation of aminobenzyl alcohol | |
JPS6342712B2 (en) | ||
JP2965679B2 (en) | Method for producing N, N, N ', N'-tetrakis (p-dialkylaminophenyl) -p-benzoquinonebis (immonium perchlorate) | |
US4624758A (en) | Electrocatalytic method for producing dihydroxybenzophenones | |
EP0100498B1 (en) | Process for the manufacture of dichlorolactic acid or the nitrile or the amide of dichlorolactic acid | |
US4323708A (en) | Method for preparing 2,4-diaminolphenol or 2,4-diamonophenol dihydrochloride | |
US4624757A (en) | Electrocatalytic method for producing quinone methides | |
JP2632832B2 (en) | Method for producing polyfluorobenzyl alcohol | |
JPS6040513B2 (en) | Production method of quaternary ammonium bromite salt | |
EP0317125A1 (en) | Process for the preparation of bromofluoromethane | |
JPS58225063A (en) | Preparation of tetrahydroindole derivative | |
JPS6140760B2 (en) | ||
HU188673B (en) | Process for the preparation of diacetone-ketogulonic acid | |
JPS632249B2 (en) | ||
JPS6396284A (en) | Production of 5-methyl-2-pyrazinecarboxylic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19830509 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19860613 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19830509 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19871223 Patent event code: PE09021S01D |
|
G160 | Decision to publish patent application | ||
PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19880623 |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19880930 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19881020 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 19881020 End annual number: 3 Start annual number: 1 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |